PIA Study Partners

Funding and Research Partners

Our clinical trial, dedicated to investigating the effects of probucol in Alzheimer’s disease, is made possible through the invaluable support of our funding and research partners.

Funding Partners

Our funding partners including MRFF, the NHMRC, MSWA, The McCusker Charitable Foundation, and the Wen Giving Foundation, provide the essential financial resources that enable us to conduct rigorous and comprehensive research. Their generous contributions ensure that we have access to the latest technologies, top-tier research facilities and the necessary support to carry out our study effectively.

Research Partners

Collaboration with esteemed research institutions including Alzheimer’s Research Australia, the Perron Institute of Neurological and Translational Research, CHIRI, the Wicking Dementia  Research and Education Centre of the University of Tasmania, and the Memory Trials Unit of the Central Adelaide Local Health Network, allows us to leverage a wealth of expertise and experience in the field of neurodegenerative diseases. These partnerships facilitate the exchange of knowledge, innovative ideas and advanced methodologies, ensuring our study is grounded in the most current and robust scientific practices.

Stronger Together

Importance of Partnerships

The synergy created by these collaborations enhances the quality and impact of our research. Our partners’ dedication to scientific excellence and their unwavering support are fundamental to achieving our objectives and ultimately improving the lives of those affected by Alzheimer’s disease.